NewsFebrurary 19
Announcement of Changes of Corporate Officers at PHC Holdings Corporation Effective March 31, April 1, 2024
Please be advised of the changes in the following Corporate Officers at PHC Holdings Corporation effective on March 31, April 1, 2024.
(1) Promotion of Corporate Officers on April 1, 2024
| Name |
New Responsibility From Apr.1, 2024 |
Responsibility Until Mar.31, 2024 |
| Nobuaki Nakamura |
Executive Corporate Officer
Head of Life Sciences/Diagnostics Domain |
Corporate Officer
Co-Head of Life Sciences/Diagnostics Domain
Head of Biomedical Business |
(2) Resignation of Corporate Officers on March 31, 2024
| Position/Title |
Name |
Remarks |
Corporate Officer
Co-head of Healthcare Solutions Domain
Head of Healthcare IT Solution Business |
Takayuki Otsuka |
President, Representative Director,
Wemex Corporation |
Corporate Officer
Co-head of Healthcare Solutions Domain
Head of LSIM Business |
Haruo Watanabe |
President and Chief Executive Officer,
LSI Medience Corporation |
(3) New Appointments of Corporate Officers on April 1, 2024
| Position/Title |
Name |
Remarks |
Corporate Officer
Head of Healthcare IT Solution Business |
Hideaki Takahashi |
Currently, Director, Healthcare IT Division, Wemex Corporation
*To be assigned to President, Representative Director,
Wemex Corporation |
| Corporate Officer
Head of LSIM Business
|
Kenichi Uchino |
Currently, Managing Director, Member of Board,
LSI Medience Corporation
*To be assigned to President and Chief Executive Officer,
LSI Medience Corporation
|
Corporate Officer
Head of Biomedical Business |
Chikara Takauo |
Currently, Deputy head of Biomedical Business |
(4) Change in Responsibilities of Corporate Officers on April 1, 2024
| Name |
New Responsibility From Apr.1, 2024 |
Responsibility Until Mar.31, 2024 |
| Koichiro Sato |
Chief Operating Officer (COO)
Head of Diabetes Management Domain
Head of Healthcare Solution Domain
|
Chief Operating Officer (COO) |
| Robert Schumm |
Corporate Officer
Head of BGM Business |
Corporate Officer
Head of Diabetes Management Domain |
| Steven Lynum |
Corporate Officer
Deputy Head of Life Sciences/Diagnostics Domain
Head of Pathology Business |
Corporate Officer
Co-Head of Life Sciences/Diagnostics Domain
Head of Pathology Business |
(5) Corporate Officers at PHC Holdings Corporation on April 1, 2024
| Position/Title |
Name |
Role and Responsibilities |
| Chief Executive Officer (CEO) |
Kyoko Deguchi |
Group Management, Internal Audit |
| Chief Operating Officer (COO) |
Koichiro Sato |
Technology, Manufacturing, Procurement, Risk Management
Head of Diabetes Management Domain,
Head of Healthcare Solutions Domain |
Senior Executive Corporate Officer
Chief Administrative Officer (CAO)
Chief Human Resources Officer (CHRO)
Chief Transformation Officer (CTO) |
Ryuichi Hirashima |
General Affairs, Human Resources, Legal & Compliance, Intellectual Property, Transformation |
Executive Corporate Officer
Chief Financial Officer (CFO) |
Frederick Reidenbach |
Corporate Accounting, Corporate Finance, Information Technology |
Executive Corporate Officer
Chief Strategy Officer (CSO) |
Kaiju Yamaguchi |
Corporate Strategic, Business Development, Investor Relations, Corporate Communications, Medical Policy & Public Affairs |
| Executive Corporate Officer |
Nobuaki Nakamura |
Head of Life Sciences/Diagnostics Domain
President, Member of Board,
PHC Corporation |
| Corporate Officer |
Robert Schumm |
Head of BGM Business President,
Ascensia Diabetes Care Holdings AG |
| Corporate Officer |
Steven Lynum |
Deputy Head of Life Sciences/Diagnostics Domain
Head of Pathology Business President,
Epredia Holdings Ltd. |
| Corporate Officer |
Kenichi Uchino |
Head of LSIM Business President and Chief Executive Officer,
LSI Medience Corporation |
| Corporate Officer |
Chikara Takauo |
Head of Biomedical Business |
| Corporate Officer |
Hideaki Takahashi |
Head of Healthcare IT Solution Business
President, Representative Director,
Wemex Corporation |
(6) Group Structure Chart